{
 "drug": "Maraviroc Solution",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "01/20/2026",
 "dayN": 217,
 "cat": "Antiviral",
 "companies": [
  "ViiV Healthcare Company"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "01/20/2026",
   "update_type": "New",
   "initial_posting_date": "01/20/2026",
   "package_ndc": "49702-260-55",
   "generic_name": "Maraviroc Solution",
   "contact_info": "877-844-8872",
   "related_info": "The anticipated date that GSK will cease distribution of the product is approximately August 1, 2026.",
   "openfda": {
    "application_number": [
     "NDA208984"
    ],
    "brand_name": [
     "SELZENTRY"
    ],
    "generic_name": [
     "MARAVIROC"
    ],
    "manufacturer_name": [
     "ViiV Healthcare Company"
    ],
    "product_ndc": [
     "49702-260",
     "49702-223",
     "49702-224"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "rxcui": [
     "728223",
     "728225",
     "729201",
     "729203",
     "1857921",
     "1857925"
    ],
    "spl_id": [
     "bd98c45d-446e-4023-882c-9c36d612f5a5"
    ],
    "spl_set_id": [
     "46f30ac5-c96b-429e-976d-8c5ee1c0761b"
    ],
    "package_ndc": [
     "49702-223-18",
     "49702-224-18",
     "49702-260-55"
    ],
    "nui": [
     "N0000175572",
     "N0000175445"
    ],
    "pharm_class_epc": [
     "CCR5 Co-receptor Antagonist [EPC]"
    ],
    "pharm_class_moa": [
     "Chemokine Co-receptor 5 Antagonists [MoA]"
    ],
    "unii": [
     "MD6P741W8A"
    ]
   },
   "update_date": "01/20/2026",
   "therapeutic_category": [
    "Antiviral"
   ],
   "dosage_form": "Solution",
   "presentation": "Selzentry, Solution, 20 mg/mL Oral Solution Kit | 230 mL Oral Solution per Bottle | 1 Bottle per Carton  (NDC 49702-260-55)",
   "company_name": "ViiV Healthcare Company",
   "status": "To Be Discontinued"
  }
 ]
}